trending Market Intelligence /marketintelligence/en/news-insights/trending/-IbIRjqKtbkJ0Nwj23q6vg2 content esgSubNav
In This List

Endologix to voluntarily recall medical device to prevent off-label use

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Endologix to voluntarily recall medical device to prevent off-label use

Endologix Inc. said it will voluntarily recall its Nellix System immediately to stop the device's unapproved use and will only sell it to pre-screened patients under current indications.

Nellix System is approved to treat abdominal aortic aneurysm, which refers to an enlarged area in the lower part of the body's major blood vessel, the aorta.

The Irvine, Calif.-based company said the device will only be made available to patients who are screened by a physician panel to ensure the product is used as intended.

The medical device maker said that data from its studies suggested that the device was being used for unapproved, or off-label, indications leading to poor outcomes.

The company is in contact with regulators on the recall and expects continued appropriate access to the device.